Medical device maker Beckman Coulter Inc. said it has acquired an Austrian company that will help Beckman customers automate processes in drug discovery, protein studies and genomics.
The Fullerton company did not disclose the purchase price for Anthos Labtec Instruments G.m.b.H. in Salzburg.
Beckman stock lost 4 cents to close at $44.66 a share on the New York Stock Exchange.
